Vera Bradley Director Acquires 92,513 Shares in Three-Day Buying Spree

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Vera Bradley director Robert J. Hall reported multiple acquisitions of common stock through the Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust in June 2025:

June 16: Acquired 37,846 shares at average price of $2.07
June 17: Acquired 30,993 shares at average price of $2.39
June 18: Acquired 23,674 shares at average price of $2.19

Following these transactions, Hall's beneficial ownership includes 2,369,380 shares through the Baekgaard Trust, 185,389 shares held directly, and additional indirect holdings through various trusts and foundations. Hall disclaims beneficial ownership of certain reported shares. The transactions were executed at price ranges between $1.89-$2.40 across multiple trades.

Insider Trade Summary

Grant/Award: 92,513 shares

Grant/Award 7 txns

Insider Hall Robert J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	23,674	$2.19	$52K
Grant/Award	Common Stock	30,993	$2.39	$74K
Grant/Award	Common Stock	37,846	$2.07	$78K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,369,380 shares (Indirect, By Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust); Common Stock — 31,358 shares (Indirect, By Barbara Bradley Baekgaard Family Foundation); Common Stock — 332,754 shares (Indirect, By Joan Byrne Hall Revocable Trust); Common Stock — 185,389 shares (Direct); Common Stock — 34,065 shares (Indirect, By Joan Byrne Hall 2017 Grantor Retained Annuity Trust #1)

Footnotes (2)

F1. The prices reported are weighted average prices. The shares sold on June 16, 2025 were sold in multiple transactions at prices ranging from $1.89 to $2.19, inclusive, the shares sold on June 17, 2025 were sold in multiple transactions at prices ranging from $2.30 to 2.40, inclusive, and the shares sold on June 18, 2025 were sold in multiple transactions at prices ranging from $2.14 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2. The reporting person disclaims beneficial ownership of these shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many VRA shares did Robert J. Hall acquire on June 16-18, 2025?

Robert J. Hall acquired a total of 92,513 shares over three days: 37,846 shares on June 16, 2025 at $2.07, 30,993 shares on June 17, 2025 at $2.39, and 23,674 shares on June 18, 2025 at $2.19. These shares were acquired through the Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust.

What is Robert J. Hall's total direct ownership of VRA stock?

According to the Form 4 filing, Robert J. Hall directly owns 185,389 shares of Vera Bradley (VRA) stock.

What positions does Robert J. Hall hold at Vera Bradley (VRA)?

According to the Form 4 filing, Robert J. Hall serves as a Director of Vera Bradley and is also listed as a member of a 10% owner group.

What is the price range of VRA shares purchased by Robert J. Hall in June 2025?

The shares were purchased at varying prices across three days: June 16 ($1.89 to $2.19), June 17 ($2.30 to $2.40), and June 18 ($2.14 to $2.21), with weighted average prices of $2.07, $2.39, and $2.19 respectively.

How many VRA shares does Robert J. Hall control indirectly through various trusts and foundations?

Hall indirectly controls 2,712,557 shares through various entities: 2,369,380 shares through the Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust, 31,358 shares through the Barbara Bradley Baekgaard Family Foundation, 332,754 shares through the Joan Byrne Hall Revocable Trust, and 34,065 shares through the Joan Byrne Hall 2017 Grantor Retained Annuity Trust #1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/18/2025 - 09:55 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hall Robert J

(Last)

(First)

(Middle)

C/O VERA BRADLEY, INC.

12420 STONEBRIDGE ROAD

(Street)

ROANOKE

46783

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Vera Bradley, Inc. [ VRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Member of a 10% owner group

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/16/2025		A		37,846	A	$2.07⁽¹⁾	2,314,713⁽²⁾	I	By Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust
Common Stock	06/17/2025		A		30,993	A	$2.39⁽¹⁾	2,345,706⁽²⁾	I	By Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust
Common Stock	06/18/2025		A		23,674⁽¹⁾	A	$2.19⁽¹⁾	2,369,380⁽²⁾	I	By Barbara B. Baekgaard 2009 Grantor Retained Annuity Trust
Common Stock								31,358⁽²⁾	I	By Barbara Bradley Baekgaard Family Foundation
Common Stock								332,754	I	By Joan Byrne Hall Revocable Trust
Common Stock								185,389	D
Common Stock								34,065	I	By Joan Byrne Hall 2017 Grantor Retained Annuity Trust #1

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The prices reported are weighted average prices. The shares sold on June 16, 2025 were sold in multiple transactions at prices ranging from $1.89 to $2.19, inclusive, the shares sold on June 17, 2025 were sold in multiple transactions at prices ranging from $2.30 to 2.40, inclusive, and the shares sold on June 18, 2025 were sold in multiple transactions at prices ranging from $2.14 to $2.21, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

2. The reporting person disclaims beneficial ownership of these shares.

	/s/ Robert J. Hall	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR